Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Diseases

Brain disorders represent 32% of the global disease burden, with 169 million Europeans affected. Constraint-based metabolic modelling and other approaches have been applied to predict new treatments for these and other diseases. Many recent studies focused on enhancing, among others, drug prediction...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishk, Ali, Pacheco, Maria Pires, Heurtaux, Tony, Sinkkonen, Lasse, Pang, Jun, Fritah, Sabrina, Niclou, Simone P., Sauter, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406599/
https://www.ncbi.nlm.nih.gov/pubmed/36010563
http://dx.doi.org/10.3390/cells11162486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406599/
https://www.ncbi.nlm.nih.gov/pubmed/36010563
http://dx.doi.org/10.3390/cells11162486

Ejemplares similares